[1]陈国华,刘声野,李波霞,等.肌间静脉血栓的抗栓治疗[J].介入放射学杂志,2023,32(09):936-941.
 CHEN Guohua,LIU Shengye,LI Boxia,et al.Antithrombotic therapy for muscular calf vein thrombosis[J].journal interventional radiology,2023,32(09):936-941.
点击复制

肌间静脉血栓的抗栓治疗()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
32
期数:
2023年09
页码:
936-941
栏目:
综述
出版日期:
2023-09-27

文章信息/Info

Title:
Antithrombotic therapy for muscular calf vein thrombosis
作者:
陈国华 刘声野 李波霞 常耀文 王文辉
Author(s):
CHEN Guohua LIU Shengye LI Boxia CHANG Yaowen WANG Wenhui.
Department of Interventional Medicine, First Hospital of Lanzhou University, Lanzhou, Gansu Province 730000, China
关键词:
【关键词】 肌间静脉血栓 孤立性远端深静脉血栓 静脉血栓栓塞 抗凝 治疗
文献标志码:
A
摘要:
【摘要】 下肢肌间静脉血栓是院内检查常见血栓形式,现较公认属于深静脉血栓范畴,但因范围和血栓负荷较小,其治疗方案与较大范围深静脉血栓有差异。本文通过对肌间静脉血栓的介绍,较详细总结了肌间静脉血栓目前国内外的抗血栓治疗等进展,认为针对血栓蔓延高危患者需抗凝治疗,低危患者可动态彩超监测,后续酌情调整治疗方案;同时提出了合并急性脑血管病、肝功能异常等情况时,抗血栓方案尚未明确、有待进一步研究的问题。

参考文献/References:

[1] 凌端强,杨 涛,郝 斌. 小腿肌间静脉丛血栓形成认识及诊治进展[J]. 血管与腔内血管外科杂志, 2015, 1: 185-189.
[2] 上海市母婴安全专家委员会,上海市医学会围产医学专科分会,上海市医学会妇产科专科分会产科学组,等. 上海市产科静脉血栓栓塞症防治的专家共识[J]. 上海医学, 2020, 43: 645-650.
[3] 贾中芝,秦 辉,汤黎明,等. 院内静脉血栓栓塞症防治体系构建的再思考[J]. 介入放射学杂志, 2020, 29:1062-1064.
[4] Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators[J]. Chest, 2011, 139: 69-79.
[5] Ruiz-Gimenez N, Suarez C, Gonzalez R, et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry[J]. Thromb Haemost, 2008,100: 26-31.
[6] Pisters R,Lane DA,Nieuwlaat R,et al. A novel user-friendly score(HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey[J]. Chest, 2010, 138: 1093-1100.
[7] 中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版)[J]. 中华普通外科杂志, 2017, 32: 807-812.
[8] 中华医学会外科学分会血管外科学组,中国医师协会血管外科医师分会,海峡两岸医药卫生交流协会血管外科分会,等.孤立性远端深静脉血栓诊疗建议[J]. 中华普通外科杂志, 2021,36: 719-721.
[9] Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report[J]. Chest, 2021, 160:e545-e608.
[10] Kakkos SK, Gohel M, Baekgaard N, et al. Editor’s choice-European Society for Vascular Surgery(ESVS) 2021 clinical practice guidelines on the management of venous thrombosis[J]. Eur J Vasc Endovasc Surg, 2021, 61:9-82.
[11] Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for  management of venous throm-boembolism: treatment of deep vein thrombosis and pulmonary  embolism[J]. Blood Adv, 2020, 4: 4693-4738.
[12] Mazzolai L,Ageno W,Alatri A,et al. Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function[J]. Eur J Prev Cardiol, 2022, 29: 1248-1263.
[13] Garry J, Duke A, Labropoulos N. Systematic review of the complications following isolated  calf deep vein thrombosis[J]. Br J Surg, 2016, 103: 789-796.
[14] Brateanu A, Patel K, Chagin K, et al. Probability of developing proximal deep-vein  thrombosis and/or pulmonary embolism after distal deep-vein thrombosis[J]. Thromb Haemost,  2016, 115: 608-614.
[15] Franco L, Giustozzi M, Agnelli G, et al. Anticoagulation in patients with isolated distal  deep vein thrombosis: a meta-analysis[J]. J Thromb Haemost, 2017, 15: 1142-1154.
[16] Wang B, Qing W, Ji Y, et al. The clinical outcomes of different doses of rivaroxaban in patients with isolated distal deep vein thrombosis[J]. J Vasc Surg Venous Lymphat Disord, 2023, 23:S2213-333X.
[17] Kelly J, Rudd A, Lewis R, et al. Venous thromboembolism after acute stroke[J]. Stroke,  2001, 32: 262-267.
[18] Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial  fibrillation[J]. Europace, 2021, 23: 1612-1676.
[19] Godoy DA, Pinero GR, Koller P, et al. Steps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhage[J]. World J Crit Care Med, 2015, 4: 213-229.
[20] Yogendrakumar V,Lun R,Khan F,et al. Venous thromboem-bolism prevention in intracerebral  hemorrhage:a systematic review and network meta-analysis[J]. PLoS One, 2020, 15: e0234957.
[21] Brott T,Broderick J,Kothari R,et al. Early hemorrhage growth in patients with  intracerebral hemorrhage[J]. Stroke, 1997, 28:1-5.
[22] Kazui S,Naritomi H,Yamamoto H,et al. Enlargement of spontaneous intracerebral hemorrhage.Incidence and time course[J]. Stroke, 1996, 27:1783-1787.
[23] 中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会,中国房颤中心联盟心房颤动防治专家工作委员会.心房颤动:目前的认识和治疗建议(2021)[J]. 中华心律失常学杂志, 2022, 26:15-88.
[24] Subhani M, Sheth A, Ahmed J, et al. Incidence and prevalence of venous thromboembolism in chronic liver disease: a systematic review and meta-analysis[J].Thromb Res,2022,215:19-29.

备注/Memo

备注/Memo:
(收稿日期:2022-10-19)
(本文编辑:茹 实)
更新日期/Last Update: 2023-09-26